Ento Key

In their recent article, Li and associates evaluate the long-term complications associated with glaucoma drainage devices (GDD) in patients who have undergone Boston type 1 keratoprosthesis (KPro) surgery. The authors…

We read with great interest the recent report by Demirci and associates describing their experience with orbital and ocular adnexal sarcoidosis. We would like to point out what we believe…

We thank Kekunnaya and associates for their interest in our recently published article, “Biomechanical Analysis of X-Pattern Exotropia.” We do agree with them that X-pattern exotropia may involve a large…

We congratulate Brandner and associates for their article, “Biomechanical Analysis of X-Pattern Exotropia,” which made for an interesting read. We have the following comments regarding the methodology and interpretation of…

We thank Drs Quaranta and Floriani for their interest in our publication. The Low-pressure Glaucoma Treatment Study (LoGTS) is a randomized trial of the effect of brimonidine versus timolol on…

The Low-Pressure Glaucoma Treatment Study is the first multicenter, randomized, double-masked, controlled clinical trial comparing the efficacy of topical twice-daily brimonidine tartrate 0.2% and twice-daily timolol maleate 0.5% in reducing…

We thank Dr Hwang and associates for their interest in and comments on our article. In our study, we determined the characteristics that were significantly associated with the visual field…

We read with great interest the article by Ohno-Matsui and associates describing the visual field (VF) defects in highly myopic eyes. They reported that progressive VF defects were newly developed…

The Low-Pressure Glaucoma Study by Krupin and associates reported a significantly lower rate of visual field progression in the brimonidine group (9%) compared to the timolol group (39%). They discuss…

Dr Garudadri and associates raise several issues. As described in our baseline and outcomes paper, we anticipated greater dropouts in the brimonidine arm, thus randomizing more patients to brimonidine than…